e-learning
resources
ERJ
2012
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Reduced nuclear factor-?B repressing factor: a link toward systemic inflammation in COPD},
Lee K.-Y., Ho S.-C., Chan Y.-F., Wang C.-H., Huang C.-D., Liu W.-T., Lin S.-M., Lo Y.-L., Chang Y.-L., Kuo L.-W., Kuo H.-P.
Source:
Eur Respir J 2012; 40: 863-873
Journal Issue:
October
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Lee K.-Y., Ho S.-C., Chan Y.-F., Wang C.-H., Huang C.-D., Liu W.-T., Lin S.-M., Lo Y.-L., Chang Y.-L., Kuo L.-W., Kuo H.-P.. Reduced nuclear factor-?B repressing factor: a link toward systemic inflammation in COPD},. Eur Respir J 2012; 40: 863-873
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
C-kit+ cell recruitment in remodelled pulmonary arteries of human PAH
Source: Annual Congress 2007 - Pathogenesis and novel therapeutic targets in pulmonary hypertension
Year: 2007
Altered scavenger receptor expression and response to oxidative stress is linked to defective bacterial phagocytosis in COPD macrophages
Source: International Congress 2016 – Mechanisms of disease
Year: 2016
DNA damage as a molecular link in the pathogenesis of COPD in smokers
Source: Eur Respir J 2012; 39: 1368-1376
Year: 2012
Interferon-β augments eosinophil adhesion-inducing activity of endothelial cells
Source: Eur Respir J 2008; 32: 1540-1547
Year: 2008
A hypothesis for the initiation of COPD
Source: Eur Respir J 2009; 33: 310-315
Year: 2009
Dual effect of neutrophils on secretory component production by human bronchial epithelial cells
Source: Annual Congress 2006 - Airway epithelial cells in inflammation
Year: 2006
Increased expression of microRNA-146a negatively regulates both the LPS and Poly (I:C) induced inflammatory response in monocytes
Source: Annual Congress 2010 - Macrophages: cell biology and disease-specific characteristics
Year: 2010
Carbonyl stress and enhanced macrophage function
Source: Annual Congress 2005 - Oxidative and nitrative stress: control of cell function in COPD
Year: 2005
Cells and mediators of chronic obstructive pulmonary disease
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=130
Year: 2006
Suppression of discoidin domain receptor 1 by RNA interference attenuates lung inflammation
Source: Annual Congress 2006 - Cellular immunology in asthma pathogenesis
Year: 2006
A central role for nuclear factor of activated T cells (NFAT) in human pulmonary arterial hypertension
Source: Annual Congress 2006 - Signalisation in the pulmonary vasculature: new pathways and wrong signals
Year: 2006
Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction
Source: Eur Respir J 2008; 31: 1334-1356
Year: 2008
Bronchial epithelial cells secrete an unknown factor that specifically activate inflammatory cytokine expression from neutrophils and peripheral blood mononuclear cells
Source: Annual Congress 2004 - Epithelial cells: critical regulation of pathogenic processes in disease
Year: 2004
Overexpression of B cell activating factor (BAFF) in peripheral lung of COPD patients
Source: Annual Congress 2009 - Pathology and immunology of COPD
Year: 2009
A role of GM-CSF in the accumulation of neutrophils in the airways caused by IL-17 and TNF-α
Source: Eur Respir J 2003; 21: 387-393
Year: 2003
Pentoxifylline (PTX) inhibits angiogenesis induced by human peripheral blood mononuclear cells (PBMC) and decreases the release of TNFα not influencing IFNγ release
Source: Eur Respir J 2001; 18: Suppl. 33, 353s
Year: 2001
Egr-1 regulates muc5ac expression through activator protein-1 (AP-1) in chronic airway inflammation diseases
Source: International Congress 2015 – Translational studies in airway cell biology
Year: 2015
Low apoptosis rate as a reason of local immune cell accumulation in interstitial lung diseases (ILD). The role of cytokine network
Source: Eur Respir J 2006; 28: Suppl. 50, 826s
Year: 2006
HLA-DP-unrestricted TNF-α release in beryllium-stimulated peripheral blood mononuclear cells
Source: Eur Respir J 2002; 20: 1174-1178
Year: 2002
Fas Ligand (FasL) expressed on alveolar lymphocytes (AL) plays role in progression of interstitial lung diseases (ILD) but not in local induction of immune cells apoptosis
Source: Eur Respir J 2005; 26: Suppl. 49, 542s
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept